New Enterprise Associates related stories
All articles and analysis
From the Filings: Ibiquity, Pinkberry & More...What follows are seven VC deals culled from recent Regulation D filings with the SEC. None of them has been otherwise disclosed: * Ibiquity Digital Corp., a Columbia, Md.-based developer of digital HD radio technology, has raised around $42.48 million in new VC funding. The company reports that half is in cash and half is an exchange offer of existing shares. Backers include ABC, Clear Channel, CBS Radio, Grotech Capital Group, JPMorgan Partners, New Venture Partners, FirstMark Capital, Ford Motor Co., Harris, Texas Instruments and Visteon. The company had previously raised over $140 million since 1999.
- peHUB Wire: Monday, July 27, 2009
Monday Mouth-Off
- Shaking The MoneyTree: VC Investment (Still) Rises in Q2
Stop me if you've heard this one before: Venture capital investing increased in the second-quarter of 2009, even though investment activity was still much lower than in Q2 2008. Oh yeah, we wrote about it over the weekend /45026/venture-capital-funding-rises-in-q2-healthcare-tops-it/ (and have been What's different this time is that the data comes from MoneyTree, a joint venture of the National Venture Capital Association, PwC and Thomson Reuters. That last one just happens to publish peHUB, which means we trust these numbers a bit more, have access to the actual database and are able to display a gluttonous smorgasborg of charts (see below). The topline number is $3.7 billion invested in 612 U.S.-based companies. This compares to $3.19 billion raised by 601 U.S.-based companies in Q1 2009, and $7.55 billion raised by 1,048 U.S.-based companies in Q2 2008. To use a semi-apt sports analogy, VCs took a baby step off the sidelines, but are nowhere near the line of scrimmage (particularly given that barely over $300 million has been invested thus far in Q3). In terms of industy sectors, IT managed to (barely) keep its unbeaten streak alive against life sciences ($1.72b vs. $1.53b). This is different than what the earlier data from Dow Jones showed, and MoneyTree does show biotech as its fattest cash cow in a more segmented analysis.
- Week in deals, July 20, 2009
Summary of North American tech companies and other businesses that raised venture-related financing in the past week
- Week in deals, July 13, 2009
Summary of tech companies and other businesses that raised financing in the past week
- SolFocus Expands Round to $77 Million
SolFocus Inc., a Palo Alto, Calif.-based developer of solar concentrator photovoltaic systems, today announced that it has expanded its Series C round to $77.6 million. The company had previously announced a $47 million first close, although peHUB reported in February that the round had expanded to around $67 million. Demeter Partners and affiliates of Advanced Equities came in as new investors, while the round also include Apex Venture Partners, New Enterprise Associates, NGEN Partners and Yellowstone Ventures. SolFocus previously raised nearly $100 million in its Series A and Series B rounds.
- peHUB Wire: Thursday, July 9, 2009
Random Ramblings
- peHUB Wire: Thursday, July 9, 2009
Random Ramblings
- Preliminary VC Deal Data Shows Mixed Bag
Venture capitalists invested $2.94 billion into 360 U.S.-based companies during the second quarter, according to preliminary, unaudited data from Thomson Reuters (publisher of peHUB). That’s down significantly from the $7.57 billion investors put into 1,042 companies during the same period in 2008, although is beginning to approach the $3.1 billion invested in Q1 2009 (and will probably top it, once all the surveys are counted). The official MoneyTree report from the National Venture Capital Association and PricewaterhouseCoopers, based on Thomson Reuters data, is expected to come out later this month. Biotechnology and health care investments buoyed the investment totals in Q2, accounting for nearly 45% of the dollars put to work during the three-month period. Four of the 10 largest deals done the quarter were health care deals. Investors put $145 million into anti-cancer company Clovis Oncology; $108 million into orthopedics company Small Bone Innovations; $50 million into light-therapy company PhotoThera; and $46 million into anti-infective medicine developer Cempra Pharmaceuticals.